Median Technologies is a biotechnology company specializing in imaging biomarkers and software solutions for the healthcare sector, particularly in oncology. The company focuses on enhancing the efficiency of clinical trials and improving patient outcomes through advanced imaging analysis and data management. Median Technologies leverages artificial intelligence and machine learning to provide innovative tools that support the development of personalized medicine and facilitate the assessment of treatment efficacy in cancer patients.